Francesca Vendemini
Overview
Explore the profile of Francesca Vendemini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vendemini F, Roncareggi S, LImperio V, Guerra F, Mottadelli F, Chiarini M, et al.
J Clin Immunol
. 2025 Feb;
45(1):77.
PMID: 39976744
Purpose: GATA2 deficiency, a rare inborn error of immunity, presents with highly variable phenotypes. Bone marrow (BM) changes such as hypocellularity and myelodysplastic syndrome (MDS) are common, with hematopoietic stem...
2.
Di Majo B, Vendemini F, Bonanomi S, Casartelli P, Napolitano S, Ottaviano G, et al.
Tumori
. 2024 Dec;
:3008916241301912.
PMID: 39688204
Introduction: The association of acute lymphoblastic leukaemia (ALL) and cystic fibrosis (CF) is rare. We present the case of a paediatric patient affected by CF and refractory B-cell precursor (BCP)...
3.
Bohlen J, Bagaric I, Vatovec T, Ogishi M, Ahmed S, Cederholm A, et al.
J Clin Invest
. 2024 Oct;
134(20).
PMID: 39403923
Patients heterozygous for germline CBL loss-of-function (LOF) variants can develop myeloid malignancy, autoinflammation, or both, if some or all of their leukocytes become homozygous for these variants through somatic loss...
4.
DellOrso G, Carlucci M, Cesaro S, Olcese E, Balduzzi A, Vendemini F, et al.
Bone Marrow Transplant
. 2024 Jun;
59(9):1302-1308.
PMID: 38909124
The optimal management of hemorrhagic cystitis (HC) in hematopoietic stem cell transplantation (HCT) is debated, both for early onset HC (EOHC) secondary to chemotherapy toxicity and BK Polyomavirus (BKPyV)-related HC,...
5.
Castelli M, Mico M, Grassi A, Algarotti A, Lussana F, Finazzi M, et al.
Bone Marrow Transplant
. 2024 May;
59(8):1161-1168.
PMID: 38773280
Transplant-associated thrombotic microangiopathy (TA-TMA) is a severe complication following hematopoietic stem cell transplantation (HSCT). No approved treatments are currently available. This study presents real-world data obtained with narsoplimab, a human...
6.
Cattoni A, Nicolosi M, Capitoli G, Gadda A, Molinari S, Louka S, et al.
Front Endocrinol (Lausanne)
. 2023 Dec;
14:1292683.
PMID: 38152128
Introduction: Impaired testosterone secretion is a frequent following hematopoietic stem cell transplantation (HSCT) in pediatrics, but long-term longitudinal trendlines of clinical and biochemical findings are still scanty. Methods: Monocentric, retrospective...
7.
Venturelli F, Leardini D, Baccelli F, Gottardi F, Barat V, Vendemini F, et al.
Eur J Pediatr
. 2023 Dec;
183(3):1137-1144.
PMID: 38095717
Conclusion: This study underscores the pressing need for unified recommendations to improve nutritional care and potentially enhance outcomes for pediatric cancer patients. What Is Known: • The assessment and support...
8.
Roncareggi S, Girardi K, Fioredda F, Pedace L, Arcuri L, Badolato R, et al.
J Clin Immunol
. 2023 Oct;
43(8):2192-2207.
PMID: 37837580
GATA2 deficiency is a rare disorder encompassing a broadly variable phenotype and its clinical picture is continuously evolving. Since it was first described in 2011, up to 500 patients have...
9.
Masetti R, Baccelli F, Leardini D, Gottardi F, Vendemini F, Di Gangi A, et al.
Blood Adv
. 2023 May;
7(16):4366-4370.
PMID: 37216275
No abstract available.
10.
Di Stasio F, Bravi M, Bonanomi S, Balduzzi A, Prunotto G, Migliorino G, et al.
Pediatr Transplant
. 2023 Mar;
27(5):e14503.
PMID: 36915258
Background: In Fanconi anemia bone marrow failure is the major cause of morbidity and mortality and hematopoietic stem cell transplantation represents the only curative treatment. Liver disease, in terms of...